跳至主要内容
临床试验/NL-OMON46988
NL-OMON46988撤回2 期

The Efficacy of TRH in Intensive Care patients; a dose finding study - The ETHIC Trial; Dose finding pilot study

Academisch Medisch Centrum0 个研究点目标入组 16 人开始时间: 待定最近更新:
适应症

试验速览

阶段
2 期
状态
撤回
入组人数
16

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 至 99(—)

入选标准

  • Admitted to the ICU for at least 1 week prior to inclusion
  • Expected duration of further stay *5 days
  • Systemic treatment with morphine or other opioids

排除标准

  • * Known pre-existing thyroid disease
  • * Treatment with drugs aimed at restoring biochemical euthyroidsm
  • (methimazole, propylthiouracil, triiodothyronine and levothyroxine) and amiodarone.
  • * Treatment with heparine at a therapeutic (thrombolytic) dose (*10.000
  • * Treatment with somatostatin or dopaminergic drugs
  • * Current glucocorticoid use or glucocorticoid use within *48 hours prior to study start
  • * Renal failure requiring dialysis or hemofiltration
  • * Pregnancy

研究者

相似试验